CA1237147A - Intermediate 4-[4-(dimethylamino)-1- (4'-fluorophenyl)-1-hydroxybutyl]-3- (hydroxymethyl)-benzonitrile and method for its preparation - Google Patents
Intermediate 4-[4-(dimethylamino)-1- (4'-fluorophenyl)-1-hydroxybutyl]-3- (hydroxymethyl)-benzonitrile and method for its preparationInfo
- Publication number
- CA1237147A CA1237147A CA000488091A CA488091A CA1237147A CA 1237147 A CA1237147 A CA 1237147A CA 000488091 A CA000488091 A CA 000488091A CA 488091 A CA488091 A CA 488091A CA 1237147 A CA1237147 A CA 1237147A
- Authority
- CA
- Canada
- Prior art keywords
- fluorophenyl
- benzonitrile
- hydroxymethyl
- preparation
- dimethylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- RVGFHORHCHHPCZ-UHFFFAOYSA-N 4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile;hydrobromide Chemical compound Br.C=1C=C(C#N)C=C(CO)C=1C(O)(CCCN(C)C)C1=CC=C(F)C=C1 RVGFHORHCHHPCZ-UHFFFAOYSA-N 0.000 title claims 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 15
- 239000002253 acid Substances 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract 4
- 239000000203 mixture Substances 0.000 claims description 14
- 239000011541 reaction mixture Substances 0.000 claims description 4
- XEEGWTLAFIZLSF-UHFFFAOYSA-N 1-oxo-3h-2-benzofuran-5-carbonitrile Chemical compound N#CC1=CC=C2C(=O)OCC2=C1 XEEGWTLAFIZLSF-UHFFFAOYSA-N 0.000 claims description 2
- -1 3-dimethylamino-propyl magnesium halide Chemical class 0.000 claims description 2
- 239000012458 free base Substances 0.000 claims 1
- 150000004820 halides Chemical class 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 239000003610 charcoal Substances 0.000 description 8
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 125000004093 cyano group Chemical group *C#N 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- 238000003747 Grignard reaction Methods 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 239000000935 antidepressant agent Substances 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 3
- IOVCWXUNBOPUCH-UHFFFAOYSA-M nitrite group Chemical group N(=O)[O-] IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- NYYRRBOMNHUCLB-UHFFFAOYSA-N 3-chloro-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCCl NYYRRBOMNHUCLB-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical group 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 150000002826 nitrites Chemical class 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 239000012485 toluene extract Substances 0.000 description 2
- WSEQXVZVJXJVFP-UHFFFAOYSA-N 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile Chemical compound O1CC2=CC(C#N)=CC=C2C1(CCCN(C)C)C1=CC=C(F)C=C1 WSEQXVZVJXJVFP-UHFFFAOYSA-N 0.000 description 1
- AITNMTXHTIIIBB-UHFFFAOYSA-N 1-bromo-4-fluorobenzene Chemical compound FC1=CC=C(Br)C=C1 AITNMTXHTIIIBB-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- PUIVIZQHTBRFTR-UHFFFAOYSA-N 3-oxo-1h-2-benzofuran-1-carbonitrile Chemical compound C1=CC=C2C(=O)OC(C#N)C2=C1 PUIVIZQHTBRFTR-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 150000004658 ketimines Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000006263 metalation reaction Methods 0.000 description 1
- RNMJRHMRVJNPGK-UHFFFAOYSA-N n,n-dimethyl-3-(1-phenyl-3h-2-benzofuran-1-yl)propan-1-amine Chemical class O1CC2=CC=CC=C2C1(CCCN(C)C)C1=CC=CC=C1 RNMJRHMRVJNPGK-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000013014 purified material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 150000003613 toluenes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Cosmetics (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Extrusion Moulding Of Plastics Or The Like (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848419963A GB8419963D0 (en) | 1984-08-06 | 1984-08-06 | Intermediate compound and method |
| GB8419963 | 1984-08-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1237147A true CA1237147A (en) | 1988-05-24 |
Family
ID=10564974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000488091A Expired CA1237147A (en) | 1984-08-06 | 1985-08-05 | Intermediate 4-[4-(dimethylamino)-1- (4'-fluorophenyl)-1-hydroxybutyl]-3- (hydroxymethyl)-benzonitrile and method for its preparation |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4650884A (cg-RX-API-DMAC10.html) |
| EP (1) | EP0171943B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JPH0625099B2 (cg-RX-API-DMAC10.html) |
| AT (1) | ATE38661T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU574819B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA1237147A (cg-RX-API-DMAC10.html) |
| DE (1) | DE3566251D1 (cg-RX-API-DMAC10.html) |
| DK (2) | DK172450B1 (cg-RX-API-DMAC10.html) |
| ES (1) | ES8606257A1 (cg-RX-API-DMAC10.html) |
| FI (2) | FI81338C (cg-RX-API-DMAC10.html) |
| GB (1) | GB8419963D0 (cg-RX-API-DMAC10.html) |
| GR (1) | GR851894B (cg-RX-API-DMAC10.html) |
| IE (1) | IE57817B1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL75690A (cg-RX-API-DMAC10.html) |
| NO (1) | NO160364C (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ212541A (cg-RX-API-DMAC10.html) |
| PT (1) | PT80913B (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA855026B (cg-RX-API-DMAC10.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003087081A1 (en) * | 2002-04-09 | 2003-10-23 | Torcan Chemical Ltd. | Process and intermediates for preparing escitalopram |
Families Citing this family (94)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
| JPH0675987U (ja) * | 1993-04-09 | 1994-10-25 | 日立造船株式会社 | 貨物輸送船におけるバラストタンクへのアクセス用トランク構造 |
| US5607939A (en) * | 1994-04-28 | 1997-03-04 | Takeda Chemical Industries, Ltd. | Condensed heterocyclic compounds, their production and use |
| CN1206207C (zh) | 1997-07-08 | 2005-06-15 | H.隆德贝克有限公司 | 氰酞氟苯胺的制备方法 |
| UA62985C2 (en) | 1997-11-10 | 2004-01-15 | Lunnbeck As H | A method for the preparation of citalopram |
| SK283907B6 (sk) | 1997-11-11 | 2004-04-06 | H. Lundbeck A/S | Spôsob výroby citalopramu a medziprodukty |
| PL199423B1 (pl) | 1998-10-20 | 2008-09-30 | Lundbeck & Co As H | Sposób wytwarzania citalopramu |
| JP2002533450A (ja) * | 1998-12-23 | 2002-10-08 | ハー・ルンドベック・アクチエゼルスカベット | ５−シアノフタリドの製造方法 |
| AR022329A1 (es) * | 1999-01-29 | 2002-09-04 | Lundbeck & Co As H | Metodo para la preparacion de 5-cianoftalida |
| HU227473B1 (en) | 1999-04-14 | 2011-07-28 | Lundbeck & Co As H | Method for preparation of citalopram |
| US6245782B1 (en) | 1999-05-17 | 2001-06-12 | Heartdrug Research L.L.C. | Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors |
| ITMI991581A1 (it) * | 1999-06-25 | 2001-01-15 | Lundbeck & Co As H | Metodo per la preparazione di citalopram |
| ITMI991579A1 (it) | 1999-06-25 | 2001-01-15 | Lundbeck & Co As H | Metodo per la preparazione di citalopram |
| ITMI991486A1 (it) * | 1999-07-06 | 2001-01-06 | Vis Farmaceutici S P A | Processo per la sintesi di citalopram |
| AR021155A1 (es) * | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
| SK287139B6 (sk) | 1999-10-25 | 2010-01-07 | H. Lundbeck A/S | Spôsob prípravy citalopramu |
| SI1228056T1 (en) | 1999-10-25 | 2005-02-28 | H. Lundbeck A/S | Method for the preparation of citalopram |
| AR026063A1 (es) | 1999-11-01 | 2002-12-26 | Lundbeck & Co As H | Metodo para la preparacion de 5-carboxiftalida. |
| MXPA02006503A (es) | 1999-12-28 | 2002-12-09 | Lundbeck & Co As H | Metodo para la preparacion de citalopram. |
| BR9917604A (pt) * | 1999-12-30 | 2002-12-31 | Lundbeck & Co As H | Método para preparação de citalopram |
| ATE252570T1 (de) | 2000-01-14 | 2003-11-15 | Lundbeck & Co As H | Verfahren zur herstellung von 5-cyanophthalid |
| AU2006201612B2 (en) * | 2000-01-14 | 2008-03-13 | H Lundbeck A/S | Method for the preparation of 5-cyanophthalide |
| NL1017415C1 (nl) | 2000-02-24 | 2001-05-18 | Lundbeck & Co As H | Werkwijze voor de bereiding van Citalopram. |
| NL1017417C1 (nl) | 2000-03-03 | 2001-03-16 | Lundbeck & Co As H | Werkwijze voor de bereiding van Citalopram. |
| PL360110A1 (en) | 2000-03-13 | 2004-09-06 | H.Lundbeck A/S | Method for the preparation of citalopram |
| IES20010206A2 (en) | 2000-03-13 | 2002-03-06 | Lundbeck & Co As H | Method for the preparation of citalopram |
| GB2357762B (en) * | 2000-03-13 | 2002-01-30 | Lundbeck & Co As H | Crystalline base of citalopram |
| NZ521204A (en) * | 2000-03-13 | 2004-03-26 | H | Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)- 1,3-dihydroisobenzofurans for preparing citalopram, an anti depressant |
| EP1265882B1 (en) | 2000-03-14 | 2004-01-14 | H. Lundbeck A/S | Method for the preparation of citalopram |
| TR200202168T2 (tr) * | 2000-03-16 | 2002-12-23 | H. Lundbeck A/S | 5-Siyano-1-(4-Florofenil)-1,3-Dihidroizobenzofuranların preparasyon metodu |
| US6494503B1 (en) * | 2000-03-25 | 2002-12-17 | Non Metallic Resources, Inc. | Pipe joint assembly and method for using same |
| US6977306B2 (en) * | 2000-05-02 | 2005-12-20 | Sumitomo Chemical Company, Limited | Citalopram hydrobromide crystal and method for crystallization thereof |
| AR032455A1 (es) | 2000-05-12 | 2003-11-12 | Lundbeck & Co As H | Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva |
| BG64901B1 (bg) * | 2000-05-29 | 2006-08-31 | H. Lundbeck A/S | Метод за получаване на циталопрам |
| CA2353693C (en) | 2000-08-10 | 2003-07-22 | H. Lundbeck A/S | Pharmaceutical composition containing citalopram |
| GB2376233B (en) * | 2000-08-10 | 2003-09-10 | Lundbeck & Co As H | Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns |
| CA2354880C (en) | 2000-08-18 | 2003-06-03 | H. Lundbeck A/S | Method for the preparation of citalopram |
| US20030109577A1 (en) * | 2000-10-27 | 2003-06-12 | Ken Liljegren | Pharmaceutical composition containing citalopram |
| US20030232881A1 (en) * | 2000-10-27 | 2003-12-18 | H. Lundbeck A/S | Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them |
| ES2228824T3 (es) | 2000-12-22 | 2005-04-16 | H. Lundbeck A/S | Metodo de preparacion de citalopram puro. |
| CA2359810C (en) * | 2000-12-28 | 2002-11-05 | H. Lundbeck A/S | Process for the preparation of pure citalopram |
| CA2435925A1 (en) * | 2001-01-30 | 2002-08-08 | Orion Corporation Fermion | Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile |
| US20050066373A1 (en) * | 2001-02-02 | 2005-03-24 | Matthew Rabinowitz | Position location using broadcast digital television signals |
| MXPA03008777A (es) * | 2001-05-01 | 2004-02-12 | Lundbeck & Co As H | El uso de escitalopram enantiomericamente puro. |
| AR034612A1 (es) * | 2001-06-25 | 2004-03-03 | Lundbeck & Co As H | Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram |
| AR034759A1 (es) * | 2001-07-13 | 2004-03-17 | Lundbeck & Co As H | Metodo para la preparacion de escitalopram |
| DK1522539T3 (da) * | 2001-07-31 | 2007-05-07 | Lundbeck & Co As H | Krystallinsk komposition indeholdende excitalopram |
| DE60108105T2 (de) * | 2001-08-02 | 2005-12-08 | Infosint Sa | Verfahren zur Herstellung von 5-substituierten Isobenzofuranen |
| EP1288211A1 (en) * | 2001-08-28 | 2003-03-05 | Sekhsaria Chemicals Ltd. | Improved process for the manufacture of citalopram hydrobromide from 5-bromophthalide |
| US6967259B2 (en) * | 2001-09-24 | 2005-11-22 | Pharmachem Technologies Limited | Process for the preparation of Citalopram intermediate |
| US7192939B2 (en) * | 2002-01-30 | 2007-03-20 | Montana State University | Pestalotiopsis microsporia isolates and compounds derived therefrom |
| GB0204607D0 (en) | 2002-02-27 | 2002-04-10 | Matrix Lab Ltd | Process |
| BG65515B1 (bg) * | 2002-07-26 | 2008-10-31 | H. Lundbeck A/S | Метод за получаване на 5-цианофталид |
| FI20021421A0 (fi) * | 2002-07-30 | 2002-07-30 | Orion Corp Fermion | Valmistusmenetelmä |
| BG65516B1 (bg) * | 2002-07-31 | 2008-10-31 | H. Lundbeck A/S | Метод за получаване на 5-цианофталид |
| TWI306846B (en) * | 2002-08-12 | 2009-03-01 | Lundbeck & Co As H | Method for the separation of intermediates which may be used for the preparation of escitalopram |
| AU2002330730A1 (en) * | 2002-08-14 | 2004-03-03 | Natco Pharma Limited | Process for the preparation of high purity citalopram and its pharmaceutically acceptable salts |
| US6812355B2 (en) | 2002-10-22 | 2004-11-02 | Sekhsaria Chemicals Limited | Process for the manufacture of citalopram hydrobromide from 5-bromophthalide |
| PL207847B1 (pl) | 2002-12-23 | 2011-02-28 | Lundbeck & Co As H | Sposób wytwarzania racemicznego 4-[4-(dimetyloamino)-1-(4'-fluorofenylo)-1- hydroksybutylo]-3-(hydroksymetylo)-benzonitrylu) i /lub R-lub S-4-[4-(dimetyloamino)-1-(4'-fluorofenylo)-1-hydroksybutylo]-3-( hydroksymetylo)- benzonitrylu) i sposób wytwarzania racemicznego citalopramu, R-citalopramu i/lub S-citalopramu |
| US20050137255A1 (en) * | 2002-12-23 | 2005-06-23 | H. Lundbeck A/S | Crystalline escitalopram hydrobromide and methods for preparing the same |
| ES2298595T3 (es) | 2002-12-23 | 2008-05-16 | H. Lundbeck A/S | Hidrobromuro de escitalopram y un metodo para su preparacion. |
| WO2004065375A1 (en) * | 2003-01-17 | 2004-08-05 | Natco Pharma Limited | Processes for the preparation of escitalopram and its precursor |
| CN1761659A (zh) * | 2003-03-21 | 2006-04-19 | H·隆德贝克有限公司 | 用于制备西酞普兰和依他普仑的中间体 |
| ATE449633T1 (de) | 2003-09-12 | 2009-12-15 | Pfizer | Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern |
| DE60300502T2 (de) * | 2003-10-28 | 2006-02-23 | Adorkem Technology S.P.A., Costa Volpino | Verfahren zur Herstellung von Citalopram |
| WO2005042473A1 (en) * | 2003-10-28 | 2005-05-12 | Wockhardt Limited | Improved process for the manufacture of citalopram hydrobromide |
| US20050143350A1 (en) * | 2003-11-19 | 2005-06-30 | Seed John C. | Combination drug therapy to treat obesity |
| CN100569765C (zh) * | 2003-12-19 | 2009-12-16 | 杭州民生药业集团有限公司 | 西酞普兰中间体晶体碱 |
| WO2005070914A1 (en) * | 2004-01-23 | 2005-08-04 | Jubilant Organosys Limited | A method for the preparation of citalopram acid addition salts |
| TWI339651B (en) * | 2004-02-12 | 2011-04-01 | Lundbeck & Co As H | Method for the separation of intermediates which may be used for the preparation of escitalopram |
| US20080119662A1 (en) * | 2004-02-16 | 2008-05-22 | Jubilant Organosys Limted | One Spot Synthesis of Citalopram from 5-Cyanophthalide |
| JP2005247710A (ja) * | 2004-03-01 | 2005-09-15 | Sumitomo Chemical Co Ltd | 光学活性シタロプラムの製造方法、その中間体およびその製造方法 |
| US20050196453A1 (en) * | 2004-03-05 | 2005-09-08 | H. Lundbeck A/S | Crystalline composition containing escitalopram |
| JP2005263741A (ja) * | 2004-03-19 | 2005-09-29 | Sumitomo Chemical Co Ltd | シタロプラムの製造方法ならびにその中間体およびその製造方法 |
| ITMI20040717A1 (it) | 2004-04-09 | 2004-07-09 | Adorkem Technology Spa | Procedimento chemo-enzimatico per la preparazione dell'escitalopram |
| KR101166280B1 (ko) * | 2004-08-23 | 2013-11-27 | 썬 파마 글로벌 에프제트이 | 시탈로프램 및 에난티오머의 제조 방법 |
| US7989645B2 (en) * | 2004-08-23 | 2011-08-02 | Sun Pharma Global Fze | Process for preparation of citalopram and enantiomers |
| ITMI20041872A1 (it) * | 2004-10-01 | 2005-01-01 | Adorkem Technology Spa | Processo per la preparazione di citalopram e di scitalopram |
| US7939680B2 (en) * | 2005-07-27 | 2011-05-10 | Aurobindo Pharma Ltd. | Process for the preparation of Escitalopram |
| EP1777221A1 (en) * | 2005-10-14 | 2007-04-25 | Adorkem Technology SpA | Process for the preparation of 5-cyanophthalide starting from 5-carboxyphthalide |
| GB0601286D0 (en) | 2006-01-23 | 2006-03-01 | Sandoz Ag | Asymmetric synthesis |
| US20080312318A1 (en) * | 2007-06-14 | 2008-12-18 | Protia, Llc | Deuterium-enriched escitalopram |
| EP2017271A1 (en) | 2007-07-06 | 2009-01-21 | Aurobindo Pharma Limited | Process for the preparation of escitalopram |
| US8022232B2 (en) | 2007-09-11 | 2011-09-20 | H. Lundbeck A/S | Method for manufacture of escitalopram |
| CN100548974C (zh) * | 2007-10-11 | 2009-10-14 | 浙江大学 | 西酞普兰中间体的萃取分离方法 |
| CN101560199B (zh) * | 2008-04-16 | 2013-09-18 | 北京德众万全药物技术开发有限公司 | 一种依地普仑的制备方法 |
| CN101265215B (zh) * | 2008-04-18 | 2011-03-16 | 浙江奥托康制药集团股份有限公司 | 一种右旋西酞普兰中间体s-型二醇的制备方法 |
| WO2010004575A2 (en) * | 2008-06-16 | 2010-01-14 | Shodhana Laboratories Limited | Preparation of escitalopram, its salts and intermediates |
| US20100087664A1 (en) * | 2008-10-07 | 2010-04-08 | Ravindra Vedantham | Preparation of citalopram and salts thereof |
| CN102190600B (zh) * | 2010-03-13 | 2015-04-15 | 浙江华海药业股份有限公司 | 一种右旋西酞普兰中间体s-型二醇的制备方法 |
| CN107848958B (zh) * | 2015-06-09 | 2020-10-23 | 浙江华海药业股份有限公司 | 一种西酞普兰二醇中间体的制备方法 |
| CN105294496A (zh) * | 2015-09-28 | 2016-02-03 | 中山大学 | 一种西酞普兰中间体的制备方法 |
| KR102134179B1 (ko) * | 2018-09-17 | 2020-07-16 | (주)유케이케미팜 | 카보네이트를 이용한 시탈로프람 및 에스시탈로프람의 새로운 제조 방법 |
| CN112409212B (zh) * | 2020-11-30 | 2023-03-14 | 四川新迪医药化工有限公司 | 西酞普兰二醇中间体氢溴酸盐的制备方法及西酞普兰二醇中间体氢溴酸盐、西酞普兰 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1143703A (cg-RX-API-DMAC10.html) * | 1965-03-18 | |||
| GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
| NL8105170A (nl) * | 1980-12-10 | 1982-07-01 | Thomae Gmbh Dr K | Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen. |
-
1984
- 1984-08-06 GB GB848419963A patent/GB8419963D0/en active Pending
-
1985
- 1985-06-25 NZ NZ212541A patent/NZ212541A/en unknown
- 1985-06-26 IE IE1603/85A patent/IE57817B1/en not_active IP Right Cessation
- 1985-07-01 IL IL75690A patent/IL75690A/xx not_active IP Right Cessation
- 1985-07-03 ZA ZA855026A patent/ZA855026B/xx unknown
- 1985-07-19 DE DE8585305168T patent/DE3566251D1/de not_active Expired
- 1985-07-19 AT AT85305168T patent/ATE38661T1/de not_active IP Right Cessation
- 1985-07-19 EP EP85305168A patent/EP0171943B1/en not_active Expired
- 1985-07-25 FI FI852902A patent/FI81338C/fi not_active IP Right Cessation
- 1985-08-01 GR GR851894A patent/GR851894B/el unknown
- 1985-08-02 US US06/761,774 patent/US4650884A/en not_active Expired - Lifetime
- 1985-08-05 NO NO853091A patent/NO160364C/no not_active IP Right Cessation
- 1985-08-05 AU AU45776/85A patent/AU574819B2/en not_active Expired
- 1985-08-05 ES ES545885A patent/ES8606257A1/es not_active Expired
- 1985-08-05 CA CA000488091A patent/CA1237147A/en not_active Expired
- 1985-08-05 PT PT80913A patent/PT80913B/pt unknown
- 1985-08-05 DK DK198503562A patent/DK172450B1/da not_active IP Right Cessation
- 1985-08-06 JP JP60171937A patent/JPH0625099B2/ja not_active Expired - Lifetime
-
1995
- 1995-08-10 DK DK199500895A patent/DK172713B1/da not_active IP Right Cessation
-
2003
- 2003-09-23 FI FI20031369A patent/FI115300B/fi active IP Right Grant
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003087081A1 (en) * | 2002-04-09 | 2003-10-23 | Torcan Chemical Ltd. | Process and intermediates for preparing escitalopram |
Also Published As
| Publication number | Publication date |
|---|---|
| NO160364C (no) | 1989-04-12 |
| US4650884A (en) | 1987-03-17 |
| FI20031369A7 (fi) | 2003-09-23 |
| IE851603L (en) | 1986-02-06 |
| FI115300B (fi) | 2005-04-15 |
| FI852902L (fi) | 1986-02-07 |
| DE3566251D1 (en) | 1988-12-22 |
| ATE38661T1 (de) | 1988-12-15 |
| PT80913B (pt) | 1987-09-30 |
| IE57817B1 (en) | 1993-04-21 |
| GR851894B (cg-RX-API-DMAC10.html) | 1985-12-03 |
| FI81338C (fi) | 1990-10-10 |
| JPH0625099B2 (ja) | 1994-04-06 |
| PT80913A (en) | 1985-09-01 |
| AU574819B2 (en) | 1988-07-14 |
| FI81338B (fi) | 1990-06-29 |
| DK172450B1 (da) | 1998-08-10 |
| ES545885A0 (es) | 1986-04-01 |
| GB8419963D0 (en) | 1984-09-12 |
| ES8606257A1 (es) | 1986-04-01 |
| NO160364B (no) | 1989-01-02 |
| ZA855026B (en) | 1986-06-25 |
| NZ212541A (en) | 1988-05-30 |
| FI852902A0 (fi) | 1985-07-25 |
| DK356285D0 (da) | 1985-08-05 |
| DK89595A (da) | 1995-08-10 |
| IL75690A (en) | 1988-10-31 |
| JPS6187654A (ja) | 1986-05-06 |
| DK172713B1 (da) | 1999-06-14 |
| EP0171943A1 (en) | 1986-02-19 |
| AU4577685A (en) | 1986-02-13 |
| DK356285A (da) | 1986-02-07 |
| EP0171943B1 (en) | 1988-11-17 |
| NO853091L (no) | 1986-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1237147A (en) | Intermediate 4-[4-(dimethylamino)-1- (4'-fluorophenyl)-1-hydroxybutyl]-3- (hydroxymethyl)-benzonitrile and method for its preparation | |
| KR970009041B1 (ko) | 비스(3,5-디옥소피페라지닐)알칸 또는 알켄을 제조하는 방법 | |
| CA1106850A (en) | 8h-indeno ¬ 2,1-b| thiophen-2-oxaminic acids and esters thereof | |
| JP3020011B2 (ja) | ヘキサヒドロピリダジン−１，２−ジカルボキシ誘導体の製造法 | |
| JPH06100487A (ja) | エーテル化合物の製造方法 | |
| US4614798A (en) | Process for the production of xylazine | |
| EP0052280B1 (en) | Process for the production of 3-amino-4,6-diacetyl phenol or a derivative thereof | |
| JPH01113333A (ja) | ３−（４’−ブロモビフェニル−４−イル）テトラリン−１−オンの製造方法 | |
| JPS6047204B2 (ja) | 窒化ケイ素粉末の製造方法 | |
| JP2812761B2 (ja) | クロロマレエートまたはクロロフマレートまたはそれらの混合物を経るアニリノフマレートの製造方法 | |
| JPS6054948B2 (ja) | α，β↓−不飽和環状脂肪族ケトキシムから芳香族アミンを製造する方法 | |
| US3959379A (en) | Preparation of primary amines | |
| JPH04273887A (ja) | モノハロアルカノイルフェロセンの合成方法 | |
| JPH0217161A (ja) | トリス（２‐シアノエチル）アミンの製造 | |
| JPH0399084A (ja) | マロンアミド誘導体金属錯体及び芳香族化合物用分離剤 | |
| US2499661A (en) | Quaternary ammonium salts of | |
| KR100376280B1 (ko) | 신남알데하이드 유도체의 제조방법 | |
| CA1053677A (en) | Process for preparing pyridinium chloride salts of alkyl esters of 2-chloro-n-2-hydroxyethylacetamide | |
| JPS6026395B2 (ja) | Ｎ−トリアルキルシリルメチル尿素の合成法 | |
| JPS6343382B2 (cg-RX-API-DMAC10.html) | ||
| JPH0576473B2 (cg-RX-API-DMAC10.html) | ||
| GB2376945A (en) | Citalopram preparation | |
| JPH08231500A (ja) | ヒドロキサメート化合物の製造方法 | |
| EP1687281A1 (en) | Synthesis of 2-chloro-3,6-dialkyl pyrazines | |
| JPH026343B2 (cg-RX-API-DMAC10.html) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |